File Download
  Links for fulltext
     (May Require Subscription)

Article: S-maltoheptaose targets syndecan-bound effectors to reduce smoking-related neutrophilic inflammation.

TitleS-maltoheptaose targets syndecan-bound effectors to reduce smoking-related neutrophilic inflammation.
Authors
Issue Date2015
Citation
Scientific Reports, 2015, v. 5, article no. 12945 How to Cite?
AbstractCigarette smoke induces injury and neutrophilic inflammation in the airways of smokers. The stability and activity of inflammatory effectors, IL8 and neutrophil elastase (NE), can be prolonged by binding to airway heparan sulfate (HS)/syndecan-1, posing risk for developing chronic obstructive pulmonary disease(COPD). We hypothesize that antagonizing HS/syndecan-1 binding of the inflammatory effectors could reduce smoking-related neutrophil-mediated airway inflammation. Analysis of bronchoalveolar lavage fluid(BALF) of COPD patients found both total and unopposed NE levels to be significantly higher among smokers with COPD than non-COPD subjects. Similar NE burden was observed in smoke-exposed rats compared to sham air controls. We chose sulfated-maltoheptaose(SM), a heparin-mimetic, to antagonize HS/sydecan-1 binding of the inflammatory mediators in airway fluids and lung tissues of the smoke-exposed rat model. Airway treatment with SM resulted in displacement of CINC-1 and NE from complexation with bronchio-epithelial HS/syndecan-1, dissipating the chemokine gradient for neutrophil flux across to the bronchial lumen. Following SM displacement of NE from shed HS/syndecan-1 in bronchial fluids, NE became accessible to inhibition by α1-antitrypsin endogenous in test samples. The antagonistic actions of SM against syndecan-1 binding of NE and CINC-1 in smoke-exposed airways suggest new therapeutic opportunities for modulating airway inflammation in smokers with SM delivery.
Persistent Identifierhttp://hdl.handle.net/10722/216601

 

DC FieldValueLanguage
dc.contributor.authorLam, CLD-
dc.contributor.authorChan, CH-
dc.contributor.authorMak, JCW-
dc.contributor.authorFreeman, C-
dc.contributor.authorIp, MSM-
dc.contributor.authorShum, DKY-
dc.date.accessioned2015-09-18T05:33:24Z-
dc.date.available2015-09-18T05:33:24Z-
dc.date.issued2015-
dc.identifier.citationScientific Reports, 2015, v. 5, article no. 12945-
dc.identifier.urihttp://hdl.handle.net/10722/216601-
dc.description.abstractCigarette smoke induces injury and neutrophilic inflammation in the airways of smokers. The stability and activity of inflammatory effectors, IL8 and neutrophil elastase (NE), can be prolonged by binding to airway heparan sulfate (HS)/syndecan-1, posing risk for developing chronic obstructive pulmonary disease(COPD). We hypothesize that antagonizing HS/syndecan-1 binding of the inflammatory effectors could reduce smoking-related neutrophil-mediated airway inflammation. Analysis of bronchoalveolar lavage fluid(BALF) of COPD patients found both total and unopposed NE levels to be significantly higher among smokers with COPD than non-COPD subjects. Similar NE burden was observed in smoke-exposed rats compared to sham air controls. We chose sulfated-maltoheptaose(SM), a heparin-mimetic, to antagonize HS/sydecan-1 binding of the inflammatory mediators in airway fluids and lung tissues of the smoke-exposed rat model. Airway treatment with SM resulted in displacement of CINC-1 and NE from complexation with bronchio-epithelial HS/syndecan-1, dissipating the chemokine gradient for neutrophil flux across to the bronchial lumen. Following SM displacement of NE from shed HS/syndecan-1 in bronchial fluids, NE became accessible to inhibition by α1-antitrypsin endogenous in test samples. The antagonistic actions of SM against syndecan-1 binding of NE and CINC-1 in smoke-exposed airways suggest new therapeutic opportunities for modulating airway inflammation in smokers with SM delivery.-
dc.languageeng-
dc.relation.ispartofScientific Reports-
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License-
dc.titleS-maltoheptaose targets syndecan-bound effectors to reduce smoking-related neutrophilic inflammation.-
dc.typeArticle-
dc.identifier.emailLam, CLD: dcllam@hku.hk-
dc.identifier.emailMak, JCW: judithmak@hku.hk-
dc.identifier.emailIp, MSM: msmip@hku.hk-
dc.identifier.emailShum, DKY: shumdkhk@hkucc.hku.hk-
dc.identifier.authorityLam, CLD=rp01345-
dc.identifier.authorityMak, JCW=rp00352-
dc.identifier.authorityIp, MSM=rp00347-
dc.identifier.authorityShum, DKY=rp00321-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1038/srep12945-
dc.identifier.scopuseid_2-s2.0-84938919736-
dc.identifier.hkuros254517-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats